Evidence map›Paper›PMID 32610142›Full record

ArticleCell reports2020

Small-Molecule Control of Super-Mendelian Inheritance in Gene Drives.

Víctor López Del Amo, Brittany S Leger, Kurt J Cox, Shubhroz Gill, Alena L Bishop, Garrett D Scanlon, James A Walker, Valentino M Gantz, Amit Choudhary

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. An optimized temporally controlled Gal4 system inFrontiers in neuroscience · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Genetic Approaches for Controlling CRISPR-based Autonomous Homing Gene Drives.Frontiers in bioengineering and biotechnology · 2022
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Víctor López Del AmoSection of Cell and Developmental Biology, University of California San Diego, La Jolla, CA 92093, USA.
Brittany S LegerCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
Kurt J CoxChemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Divisions of Renal Medicine and Engineering, Brigham and Women's Hospital, Boston, MA 02115, USA.
Shubhroz GillChemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Alena L BishopSection of Cell and Developmental Biology, University of California San Diego, La Jolla, CA 92093, USA.
Garrett D ScanlonCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
James A WalkerCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: jwalker@helix.mgh.harvard.edu.
Valentino M GantzSection of Cell and Developmental Biology, University of California San Diego, La Jolla, CA 92093, USA. Electronic address: vgantz@ucsd.edu.
Amit ChoudharyChemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Divisions of Renal Medicine and Engineering, Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address: achoudhary@bwh.harvard.edu.
Broad Institute · USUniversity of California, San Diego · USMassachusetts General Hospital · USHarvard University · US

Funding

Development, characterization and application of CRISPR/Cas9 gene drive technologies and related active genetic elements to benefit research and society at largeDP5OD023098 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GANTZ, VALENTINO MATTEO · 2016 to 2020
$1.9M
Development of synthetic gene drives using small moleculesR01GM132825 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI AKBARI, OMAR SULTAN, CHOUDHARY, AMIT · 2019 to 2022
$1.4M
Identification of potent small molecule inhibitors of Cas9R21AI126239 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI CHOUDHARY, AMIT · 2016 to 2017
$488k
NIAID NIH HHS R21 AI126239NIGMS NIH HHS R01 GM132825NIH HHS DP5 OD023098
6 · The paper itself

Abstract

Synthetic CRISPR-based gene-drive systems have tremendous potential in public health and agriculture, such as for fighting vector-borne diseases or suppressing crop pest populations. These elements can rapidly spread in a population by breaching the inheritance limit of 50% dictated by Mendel's law of gene segregation, making them a promising tool for population engineering. However, current technologies lack control over their propagation capacity, and there are important concerns about potential unchecked spreading. Here, we describe a gene-drive system in Drosophila that generates an analog inheritance output that can be tightly and conditionally controlled to between 50% and 100%. This technology uses a modified SpCas9 that responds to a synthetic, orally available small molecule, fine-tuning the inheritance probability. This system opens a new avenue to feasibility studies for spatial and temporal control of gene drives using small molecules.

Indexed as

Gene Drive TechnologyAnimalsAnimals, Genetically ModifiedCRISPR-Associated Protein 9Drosophila melanogasterInheritance PatternsPharmaceutical PreparationsSmall Molecule LibrariesCRISPR-Associated Protein 9Pharmaceutical PreparationsSmall Molecule LibrariesCopyCatCRISPRdestabilized domainDHFRDrosophiladrug controlgene drivesmall moleculesplit gene drivesuper-Mendelian

Identifiers

PMID32610142
PMCPMC7587219
OpenAlexW3039771396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.